Radiation-Triggered Selenium-Engineered Mesoporous Silica Nanocapsules for RNAi Therapy in Radiotherapy-Resistant Glioblastoma
- 9 February 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (4) , 4062-4076
Abstract
Radiotherapy-resistant glioblastoma (rrGBM) remains a significant clinical challenge because of high infiltrative growth characterized by activation of antiapoptotic signal transduction. Herein, we describe an efficiently biodegradable selenium-engineered mesoporous silica nanocapsule, initiated by high-energy X-ray irradiation and employed for at-site RNA interference (RNAi) to inhibit rrGBM invasion and achieve maximum therapeutic benefit. Our radiation-triggered RNAi nanocapsule showed high physiological stability, good blood-brain barrier transcytosis, and potent rrGBM accumulation. An intratumoral RNAi nanocapsule permitted low-dose X-ray radiation-triggered dissociation for cofilin-1 knockdown, inhibiting rrGBM infiltration. More importantly, tumor suppression was further amplified by electron-affinity aminoimidazole products converted from metronidazole polymers under X-ray radiation-exacerbated hypoxia, which sensitized cell apoptosis to ionizing radiation by fixing reactive oxygen species-induced DNA lesions. In vivo experiments confirmed that our RNAi nanocapsule reduced tumor growth and invasion, prolonging survival in an orthotopic rrGBM model. Generally, we present a promising radiosensitizer that would effectively improve rrGBM-patient outcomes with low-dose X-ray irradiation.Keywords
Funding Information
- National Natural Science Foundation of China (81902535, 81972350)
- Medical Science and Technology Development Foundation of Nanjing (JQX22008)
This publication has 50 references indexed in Scilit:
- In Situ Synthesis of Ultrathin ZIF-8 Film-Coated MSNs for Codelivering Bcl 2 siRNA and Doxorubicin to Enhance Chemotherapeutic Efficacy in Drug-Resistant Cancer CellsACS Applied Materials & Interfaces, 2018
- Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease TherapyTrends in Biotechnology, 2018
- pH-Responsive Magnetic Mesoporous Silica-Based Nanoplatform for Synergistic Photodynamic Therapy/ChemotherapyACS Applied Materials & Interfaces, 2018
- Traceable Nanoparticles with Dual Targeting and ROS Response for RNAi‐Based Immunochemotherapy of Intracranial Glioblastoma TreatmentAdvanced Materials, 2018
- Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplexBiomaterials, 2017
- MET signaling promotes DNA repair and radiation resistance in glioblastoma stem-like cellsAnnals of Translational Medicine, 2017
- Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic–Inorganic Hybridization into FrameworksAdvanced Materials, 2016
- The Actin Depolymerizing Factor (ADF)/Cofilin Signaling Pathway and DNA Damage Responses in CancerInternational Journal of Molecular Sciences, 2015
- Increasing radiosensitivity with the downregulation of cofilin-1 in U251 human glioma cellsMolecular Medicine Reports, 2014
- Over‐Expression of Cofilin‐1 and Phosphoglycerate Kinase 1 in Astrocytomas Involved in Pathogenesis of RadioresistanceCNS Neuroscience & Therapeutics, 2012